Autotransfusion Devices Market size is estimated to surpass USD 400 million by the end of 2033, growing at a CAGR of 6% during the forecast period, i.e., 2023-2033. In the year 2022, the industry size of autotransfusion devices was over USD 250 million. The growth of the market can primarily be ascribed to the number of patients in need of surgical care. As per the WHO, over 2 million surgical procedures were performed in 2018 across the globe. Moreover, instances of surgical burden are to expected rise by approximately 30% in the next few years.
The rising need for blood donation and increased volumes of donated blood, combined with the rising need for blood transfusion, is expected to boost the growth of the global autotransfusion devices market. As per the reported data, globally, every year about 118.5 million units of donated blood are collected. Additionally, in India, nearly 25-30 thousand people require liver transplants and about 50,000 person gets a heart attack. Furthermore, around 6,721 people are waiting for organ transplantation in the United Kingdom.
Autotransfusion is the procedure of transferring a patient's own blood into their body during cardiac or orthopedic surgery after component separation, and filtration. On the other hand, allogeneic blood transfusions can result in tumor progression, post-operative infections, severe lung injury, post-operative cardiovascular failures, and early death. For instance, multiple patient-based analysts predict that the pervasiveness of transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) in the United States is about 1.0% and 0.1%, respectively. As a result, shifting the priority forward into cell salvage can greatly decrease the need for allogeneic blood transfusion, decreasing the likelihood of detrimental ailments. As a result, the switch toward autologous blood transfusion is an eminent trend that is predicted to drive the market’s growth.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~USD 250 Million |
|
Forecast Year Market Size (2033) |
~USD 400 Million |
|
Regional Scope |
|
Application (Orthopedic, Cardiovascular, Neurological, Gynecological, Obstetrics, Other Surgeries)
The autotransfusion devices market is segmented and analyzed for demand and supply by application into orthopedic, cardiovascular, neurological, gynecological, obstetrics, and other surgeries. Out of all, the cardiovascular surgery segment is anticipated to hold the largest market size by the end of 2033. Increased instances of cardiovascular issues are creating higher demands for transplantation, surgery, and autotransfusion, which is likely to drive the growth of the segment. According to the World Health Organization, nearly 17.9 million people are dying of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.
Product Type (Autotransfusion Systems, Accessories)
The autotransfusion devices market is segmented and analyzed for demand and supply by product type into autotransfusion systems, and accessories. Out of all, autotransfusion systems are expected to hold the highest market size by the end of 2033. Owing to their reliability in blood transfusion, autotransfusion systems are becoming more popular in both developed and emerging nations, which is predicted to propel expansion in this segment over the coming years. Furthermore, adaptability, transfusion reporting mechanisms, technological developments for enhanced clinical outcomes, and communication are predicted to propel the expansion of the dual-mode autotransfusion systems segment in the market by 2033. In November 2022, LivaNova US introduced the XtraTM autotransfusion system, which serves as a full blood management system. It combines three decades of expertise and advancements in cell salvage methods.
Our in-depth analysis of the global market includes the following segments:
|
By Application |
|
|
By Product Type |
|
|
By End User |
|
APAC Market Statistics
On the other hand, the Asia Pacific market is projected to expand at the fastest CAGR owing to the entry of new industry players, and the increasing acceptance of cell salvage technologies. Furthermore, the steadily expanding number of surgeries performed in China and India, along with the emerging health services, are expected to create significant growth possibilities for the region. According to the most recent statistical report, Chinese hospitals operated more than 81 million inpatient surgeries in 2021.
North American Market Forecast
The North America autotransfusion devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be ascribed to the account of higher cases of chronic disease among the population propelling the market growth in the United States. According to the Centers for Disease Control and Prevention, every 6 in 10 adults are living with a chronic disease, and every 4 in 10 have more than 1 chronic problem. Furthermore, there has been a rise in organ transplantation and other surgeries in the region, that is further predicted to surge the market’s growth in the region. In the United States, at the current time, nearly 121,000 people are waiting for kidney transplantation. Also, the region's sales growth is expected to be driven by the rising usage of autologous blood transfusion in significant cardiovascular and orthopedic surgeries, in addition to the existence of established healthcare facilities. For instance, as per the American Association of Blood Banks guidelines, postoperative and intraoperative autotransfusion are conducted in surgeries in which 20% of overall surgical bleeding is anticipated.
ProCell Surgical Inc. announces its first patient blood management device, ProCell. Procell’s Sponge Blood Recovery is the extraction of blood during the surgical process in intraoperative transfusion.
Haemnotics Corporation join hands with Epic, a leading company for delivering electronic health record systems, to provide innovative medical solutions and better results for patients.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?